Why Icatibant Injection?
Icatibant Injection treats all types of acute HAE attacks, including skin (cutaneous), stomach (abdominal), and throat (laryngeal).
Fresenius Kabi’s FDA-approved generic Icatibant Injection offers patients an affordable, fully substitutable, chemically equivalent* option in treating acute attacks of Hereditary angioedema (HAE). Icatibant Injection is indicated for the treatment of acute attacks of HAE in adults 18 years of age and older.
Convenient, on-demand treatment gives you the confidence you need to live freely, knowing you have a medicine you can use at the first signs of HAE symptoms.
Talk to your doctor to see if Icatibant Injection is the right on-demand treatment for you.